Early recognition of malnutrition and cachexia in the cancer patient: A position paper of a European School of Oncology Task Force

Annals of Oncology

Volumn 25, Issue 8, 2014, Pages 1492-1499

  Aapro, M ^a   Arends, J ^b   Bozzetti, F ^c   Fearon, Ken ^d   Grunberg, S M ^e   Herrstedt, J ^f   Hopkinson, J ^g   Jacquelin Ravel, N ^a   Jatoi, A ^h   Kaasa, S ⁱ   Strasser, F ^j  

^a CLINIQUE DE GENOLIER   (Switzerland)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^f ODENSE UNIVERSITY HOSPITAL   (Denmark)

^g CARDIFF UNIVERSITY   (United Kingdom)

^h MAYO CLINIC   (United States)

ⁱ NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^j CANTONAL HOSPITAL ST GALLEN   (Switzerland)

more..

Author keywords

Cancer cachexia; Malnutrition; Nutritional support; Review; Systemic inflammation

Indexed keywords

ANAMORELIN; ANDROGEN RECEPTOR; BIMAGRUMAB; CYTOKINE; CYTOKINE RECEPTOR ANTAGONIST; ENOBOSARM; GHRELIN RECEPTOR; LY 2495655; MYOSTATIN; UNCLASSIFIED DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; DRUG;

BODY COMPOSITION; CACHEXIA; CALORIC INTAKE; CANCER PATIENT; CANCER THERAPY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DRUG TARGETING; EARLY DIAGNOSIS; HUMAN; INFLAMMATION; MUSCLE MASS; MUSCLE STRENGTH; NUTRITIONAL SUPPORT; PATIENT CARE; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN INTAKE; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; TREATMENT DURATION; TREATMENT RESPONSE; CLINICAL PRACTICE; DISEASE SEVERITY; EARLY INTERVENTION; FOOD INTAKE; FUNCTIONAL STATUS; KINESIOTHERAPY; MALNUTRITION; NUTRITIONAL ASSESSMENT; NUTRITIONAL HEALTH; PATHOPHYSIOLOGY; PATIENT IDENTIFICATION; PATIENT INFORMATION; PATIENT MONITORING; COMPLICATION; MOLECULARLY TARGETED THERAPY; NEOPLASMS; PHYSIOLOGY; PRACTICE GUIDELINE; PROGNOSIS; WEIGHT REDUCTION;

BODY COMPOSITION; CACHEXIA; EARLY DIAGNOSIS; HUMANS; MALNUTRITION; MOLECULAR TARGETED THERAPY; NEOPLASMS; PHARMACEUTICAL PREPARATIONS; PHYSICIAN'S PRACTICE PATTERNS; PROGNOSIS; WEIGHT LOSS;

EID: 84904049643     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdu085     Document Type: Review

References (59)

1. Von Haeling S, Anker SD. Cachexia as a major underestimated and unmet medical need: facts and numbers. J Cachexia Sarcopenia Muscle 2010; 1: 1-5.
2. Hopkinson J, Wright D, Corner J. Exploring the experience of weight loss in people with advanced cancer. J Adv Nursing 2006; 54: 304-312.
3. Churm D, Andrew IM, Holden K et al. A questionnaire study of the approach to the anorexia-cachexia syndrome in patients with cancer by staff in a district general hospital. Support Care Cancer 2009; 17: 503-507.
4. Jacquelin-Ravel N, Pichard C. Clinical nutrition, body composition and oncology: a critical review of the synergies. Crit Rev Oncol Hematol 2012; 84: 37-46.
5. Fearon KC, Glass DJ, Guttridge DC. Cancer cachexia: mediators, signaling and metabolic pathways. Cell Metab 2012; 16: 153-166.
6. Skipworth RJE, Stewart GD, Dejong CHC et al. Pathophysiology of cancer cachexia: much more than host-tumour interaction? Clin Nutr 2007; 26: 667-676.
7. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
8. McMillan DC. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 2009; 12: 223-226.
9. Fearon KC. The 2011 ESPEN Arvid Wretlind lecture. Cancer cachexia: the potential impact of translational research on patient-focused outcomes. Clin Nutr 2012; 31: 577-582.
10. Temel JS, Greer JA, Muzikansky A et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010; 363: 733-742.
11. Dewys WD, Begg C, Lavin PT. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 1980; 69: 491-497.
12. Wheelwright S, Darlington AS, Hopkinson JB et al. A systematic review of healthrelated quality of life instruments in patients with cancer cachexia. Support Care Cancer 2013; 21: 2625-2636.
13. Arrieta O, Michel Ortega RM, Villanueva-Rodriguez G et al. Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study. BMC Cancer 2010; 10: 50.
14. Andreyev HJN, Norman AR, Oates J et al. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 1998; 34: 503-509.
15. Ross PJ, Ashley S, Norton A et al. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? Br J Cancer 2004; 90: 1905-1911.
16. Bachmann J, Heiligensetzer M, Krakowski-Roosen H et al. Cachexia worsens prognosis in patients with resectable pancreatic cancer. J Gastrointest Surg 2008; 12: 1193-1201.
17. Dechaphunkul T, Martin L, Alberda C et al. Malnutrition assessment in patients with cancers of the head and neck: a call to action and consensus. Crit Rev Oncol Hematol 2013; 88: 459-476.
18. Isenring EA, Capra S, Bauer JD. Nutrition intervention is beneficial in oncology outpatients receiving radiotherapy to the gastrointestinal or head and neck area. Br J Cancer 2004; 91: 447-452.
19. Ravasco P, Monteiro-Grillo I, Camilo M. Individualized nutrition intervention is of major benefit to colorectal cancer patients: long-term follow-up of a randomized controlled trial of nutritional therapy. Am J Clin Nutr 2012; 96: 1346-1353.
20. White JV, Guenter P, Jensen G et al. ASPEN Malnutrition Task Force. Consensus statement: Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition: characteristics recommended for the identification and documentation of adult malnutrition (undernutrition). J Parenter Enteral Nutr 2012; 36: 275-283.
21. Fearon KC, Voss AC, Hustead DS for the Cancer Cachexia Study Group. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 2006; 83: 1345-1350.
22. Muscaritoli M, Anker SD, Argiles J et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". Clin Nutr 2010; 29: 154-159.
23. Bozzetti F, Mariani L. Defining and classifying cancer cachexia: a proposal by the SCRINIO Working Group. J Parenter Enteral Nutr 2009; 33: 361-367.
24. Fearon K, Strasser F, Anker SD. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011; 12: 489-495.
25. Tan BHL, Fladvad T, Braun TP et al. P-selectin genotype is associated with the development of cancer cachexia. EMBO Mol Med 2012; 4: 462-471.
26. Gallagher I, Stephens NA, MacDonald AJ et al. Suppression of skeletal muscle turnover in cancer cachexia: evidence from the transcriptome in sequential human muscle biopsies. Clin Cancer Res 2012; 18: 2817-2827.
27. Gioulbasanis I, Georgoulias P, Vlachostergios PJ et al. Mini Nutritional Assessment (MNA) and biochemical markers of cachexia in lung cancer patients: interrelations and associations with prognosis. Lung Cancer 2011; 74: 516-520.
28. Wallengren O, Lundholm K, Bosaeus I. Diagnostic criteria of cancer cachexia: relation to quality of life, exercise capacity and survival in unselected palliative care patients. Support Cancer Care 2013; 21: 1569-1577.
29. Blum D, Omlin A, Baracos VE et al. Cancer cachexia: a systematic literature review of items and domains associated with involuntary weight loss in cancer. Crit Rev Oncol Hematol 2011; 80: 114-144.
30. Skipworth JR, Stewart GD, Bhana M et al. Mass spectrometric detection of candidate protein biomarkers of cancer cachexia in human urine. Int J Oncol 2010; 36: 973-982.
31. Deans DA, Tan BH, Wigmore SJ et al. The influence of systemic inflammation, dietary intake, and stage of disease on rate of weight loss in patients with gastrooesophageal cancer. Br J Cancer 2009; 100: 63-69.
32. Baracos VE, Reiman T, Mourtzakis M et al. Body composition in patients with nonsmall cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis. Am J Clin Nutr 2010; 91:1133S-1137S.
33. Murphy RA, Wilke MS, Perrine M et al. Loss of adipose tissue and plasma phospholipids: relationship to survival in advanced cancer patients. Clin Nutr 2010; 29: 482-487.
34. Gupta D, Lammersfeld CA, Vashi PG et al. Bioelectrical impedance phase angle as a prognostic indicator in breast cancer. BMC Cancer 2008; 8: 249.
35. Gupta D, Lammersfeld CA, Burrows JL et al. Bioelectrical impedance phase angle in clinical practice: implications for prognosis in advanced colorectal cancer. Am J Clin Nutr 2004; 80: 1634-1638.
36. Mariani L, Lo Vullo S, Bozzetti F. SCRINIO Working Group. Weight loss in cancer patients: a plea for a better awareness of the issue. Support Care Cancer 2012; 20: 301-309.
37. Bozzetti F, Arends J, Lundholm K et al. ESPEN Guidelines on parenteral nutrition: non-surgical oncology. Clin Nutr 2009; 28: 445-454.
38. McMillan DC. The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev 2013; 39: 534-540.
39. Laird BJ, Kaasa S, McMillan DC et al. Prognostic factors in patients with advanced cancer: a comparison of clinicopathological prognostic factors and the development of an inflammation-based prognostic system. Clin Cancer Res 2013; 19: 5456-5464.
40. Von Haeling S, Stepney R, Anker SD. Advances in understanding and treating cardiac cachexia: highlights from the 5th Cachexia Conference. Int J Cardiol 2010; 144: 347-349.
41. Isenring E, Capra S, Bauer J et al. The impact of nutrition support on body composition in cancer outpatients receiving radiotherapy. Acta Diabetol 2003; 40: S162-S164.
42. Baldwin C, Spiro A, Ahern R et al. Oral nutritional interventions in malnourished patients with cancer: a systematic review and meta-analysis. J Natl Cancer Inst 2012; 104: 371-385.
43. Ravasco P, Monteiro-Grillo I, Vidal PM et al. Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy. J Clin Oncol 2005; 23: 1431-1438.
44. Percival C, Hussain A, Zadora-Chrzastowska S et al. Providing nutritional support to patients with thoracic cancer: findings of a dedicated rehabilitation service. Respir Med 2013; 107: 753-761.
45. Ries A, Trottenberg P, Elsner F. A systematic review on the role of fish oil for the treatment of cachexia in advanced cancer: an EPCRC cachexia guidelines project. Palliat Med 2012; 26: 294-304.
46. Murphy RA, Yeung E, Mazurak VC et al. Influence of eicosapentaenoic acid supplementation on lean body mass in cancer cachexia. Br J Cancer 2011; 105: 1469-1473.
47. van der Meij BS, Van Bokhorst-de van der Schueren MAE, Langius JAE. n-3 PUFAs in cancer, surgery, and critical care: a systematic review on clinical benefits, incorporation, and washout of oral or enteral compared with parenteral supplementation. Am J Clin Nutr 2011; 94: 1248-1265.
48. Solheim TS, Fearon KCH, Blum D et al. Non-steroidal anti-inflammatory treatment in cancer cachexia: a systematic literature review. Acta Oncol 2013; 52: 6-17.
49. Maddocks M, Murton AJ, Wilcock A. Therapeutic exercise in cancer cachexia. Crit Rev Oncol 2012; 17: 285-292.
50. Solheim TS, Laird BJ. Evidence base for multimodal therapy in cachexia. Curr Opin Support Palliat Care 2012; 6: 424-431.
51. Muscaritoli M, Molfino A, Gioia G et al. The "parallel pathway": a novel nutritional and metabolic approach to cancer patients. Intern Emerg Med 2011; 6: 105-112.
52. Dulloo AG. Regulation of body composition during weight recovery: integrating the control of energy partitioning and thermogenesis. Clin Nutr 1997; 16(Suppl 1): 25-35.
53. van der Meij BS, Langius JA, Spreeuwenberg MD et al. Oral nutritional supplements containing n-3 polyunsaturated fatty acids affect quality of life and functional status in lung cancer patients during multimodality treatment: an RCT. Eur J Clin Nutr 2012; 66: 399-404.
54. Murphy R, Mourtzakis M, Chu QS et al. Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer. Cancer 2011; 117: 3774-3780.
55. Awad S, Tan BH, Cui H et al. Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer. Clin Nutr 2012; 31: 74-77.
56. Martin L, Birdsell L, Macdonald N et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 2013; 31: 1539-1547.
57. Antoun S, Birdsell L, Sawyer MB. Association of skeletal muscle wasting with treatment with sorafenib in patients with advanced renal cell carcinoma: results from a placebo-controlled study. J Clin Oncol 2010; 28: 1054-1060.
58. Luciani A, Ascione G, Bertuzzi C. The impact of chemotherapy on body composition and functional status in elderly cancer patients. Crit Rev Oncol Hematol 2009; 72S1: 96.
59. Oberholzer R, Hopkinson JB, Baumann K et al. Psychosocial effects of cancer cachexia: a systamatic literature search and qualitative analysis. J Pain Symptom Manage 2013; 46: 77-95.